Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy
Gespeichert in:
| Veröffentlicht in: | European journal of clinical pharmacology 2013-04, Vol.69 (4), p.1037-1039 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1039 |
|---|---|
| container_issue | 4 |
| container_start_page | 1037 |
| container_title | European journal of clinical pharmacology |
| container_volume | 69 |
| creator | Desaphy, Jean-François Modoni, Anna LoMonaco, Mauro Camerino, Diana Conte |
| description | |
| doi_str_mv | 10.1007/s00228-012-1414-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3621996</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3318056981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-e839e9b8a63ccac68d8d839190388cb62bf192cecbf551989ff507a42e85c6223</originalsourceid><addsrcrecordid>eNp1UcuKFDEUDaI47egHuJGAuIzmUY_EhTCMTxhwo-twK32rO0NVUibpGfoH_G7TdjuOC8kihHteN4eQ54K_Fpz3bzLnUmrGhWSiEQ1TD8hKNKq-eCMekhXnSrDO9PyMPMn5mnPRGq4ekzOpeCsboVbk5_sEMxTvqJ-XFG9wxlBoHOm8jyUGD3TBNEPAkOmtL1s6TujAB7_GtxRouY3MQUaacInpN7EyYs5-mJAOGNyWlcgGXOfKoMsWqpiLGwxYPTPNJUHBzf4peTTClPHZ6T4n3z9--Hb5mV19_fTl8uKKuabrC0OtDJpBQ6ecA9fpdT3KiLqV1m7o5DAKIx26YWxbYbQZx5b30EjUreukVOfk3VF32Q0zrl1dNsFkl-RnSHsbwdt_J8Fv7SbeWNVJYUxXBV6eBFL8scNc7HXcpVAzW9HKitC80RUljiiX6l8kHO8cBLeH6uyxOlurs4fqrKqcF_ej3TH-dFUBr04AyA6mMUFwPv_F9UrLvjtElEdcrqOwwXQv4n_dfwH-g7SR</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1529968048</pqid></control><display><type>article</type><title>Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Desaphy, Jean-François ; Modoni, Anna ; LoMonaco, Mauro ; Camerino, Diana Conte</creator><creatorcontrib>Desaphy, Jean-François ; Modoni, Anna ; LoMonaco, Mauro ; Camerino, Diana Conte</creatorcontrib><identifier>ISSN: 0031-6970</identifier><identifier>EISSN: 1432-1041</identifier><identifier>DOI: 10.1007/s00228-012-1414-3</identifier><identifier>PMID: 23052413</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Diseases of striated muscles. Neuromuscular diseases ; Female ; Flecainide - administration & dosage ; Flecainide - therapeutic use ; Humans ; Letter to the Editors ; Male ; Medical sciences ; Mutation ; Myotonia Congenita - drug therapy ; Myotonia Congenita - genetics ; NAV1.4 Voltage-Gated Sodium Channel - genetics ; Neurology ; Nuclear Family ; Pharmacogenetics ; Pharmacology. Drug treatments ; Pharmacology/Toxicology ; Treatment Outcome ; Voltage-Gated Sodium Channel Blockers - administration & dosage ; Voltage-Gated Sodium Channel Blockers - therapeutic use</subject><ispartof>European journal of clinical pharmacology, 2013-04, Vol.69 (4), p.1037-1039</ispartof><rights>The Author(s) 2012</rights><rights>2014 INIST-CNRS</rights><rights>Springer-Verlag Berlin Heidelberg 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-e839e9b8a63ccac68d8d839190388cb62bf192cecbf551989ff507a42e85c6223</citedby><cites>FETCH-LOGICAL-c467t-e839e9b8a63ccac68d8d839190388cb62bf192cecbf551989ff507a42e85c6223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00228-012-1414-3$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00228-012-1414-3$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,777,781,882,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27382766$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23052413$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Desaphy, Jean-François</creatorcontrib><creatorcontrib>Modoni, Anna</creatorcontrib><creatorcontrib>LoMonaco, Mauro</creatorcontrib><creatorcontrib>Camerino, Diana Conte</creatorcontrib><title>Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy</title><title>European journal of clinical pharmacology</title><addtitle>Eur J Clin Pharmacol</addtitle><addtitle>Eur J Clin Pharmacol</addtitle><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Diseases of striated muscles. Neuromuscular diseases</subject><subject>Female</subject><subject>Flecainide - administration & dosage</subject><subject>Flecainide - therapeutic use</subject><subject>Humans</subject><subject>Letter to the Editors</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mutation</subject><subject>Myotonia Congenita - drug therapy</subject><subject>Myotonia Congenita - genetics</subject><subject>NAV1.4 Voltage-Gated Sodium Channel - genetics</subject><subject>Neurology</subject><subject>Nuclear Family</subject><subject>Pharmacogenetics</subject><subject>Pharmacology. Drug treatments</subject><subject>Pharmacology/Toxicology</subject><subject>Treatment Outcome</subject><subject>Voltage-Gated Sodium Channel Blockers - administration & dosage</subject><subject>Voltage-Gated Sodium Channel Blockers - therapeutic use</subject><issn>0031-6970</issn><issn>1432-1041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1UcuKFDEUDaI47egHuJGAuIzmUY_EhTCMTxhwo-twK32rO0NVUibpGfoH_G7TdjuOC8kihHteN4eQ54K_Fpz3bzLnUmrGhWSiEQ1TD8hKNKq-eCMekhXnSrDO9PyMPMn5mnPRGq4ekzOpeCsboVbk5_sEMxTvqJ-XFG9wxlBoHOm8jyUGD3TBNEPAkOmtL1s6TujAB7_GtxRouY3MQUaacInpN7EyYs5-mJAOGNyWlcgGXOfKoMsWqpiLGwxYPTPNJUHBzf4peTTClPHZ6T4n3z9--Hb5mV19_fTl8uKKuabrC0OtDJpBQ6ecA9fpdT3KiLqV1m7o5DAKIx26YWxbYbQZx5b30EjUreukVOfk3VF32Q0zrl1dNsFkl-RnSHsbwdt_J8Fv7SbeWNVJYUxXBV6eBFL8scNc7HXcpVAzW9HKitC80RUljiiX6l8kHO8cBLeH6uyxOlurs4fqrKqcF_ej3TH-dFUBr04AyA6mMUFwPv_F9UrLvjtElEdcrqOwwXQv4n_dfwH-g7SR</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Desaphy, Jean-François</creator><creator>Modoni, Anna</creator><creator>LoMonaco, Mauro</creator><creator>Camerino, Diana Conte</creator><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>5PM</scope></search><sort><creationdate>20130401</creationdate><title>Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy</title><author>Desaphy, Jean-François ; Modoni, Anna ; LoMonaco, Mauro ; Camerino, Diana Conte</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-e839e9b8a63ccac68d8d839190388cb62bf192cecbf551989ff507a42e85c6223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Diseases of striated muscles. Neuromuscular diseases</topic><topic>Female</topic><topic>Flecainide - administration & dosage</topic><topic>Flecainide - therapeutic use</topic><topic>Humans</topic><topic>Letter to the Editors</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mutation</topic><topic>Myotonia Congenita - drug therapy</topic><topic>Myotonia Congenita - genetics</topic><topic>NAV1.4 Voltage-Gated Sodium Channel - genetics</topic><topic>Neurology</topic><topic>Nuclear Family</topic><topic>Pharmacogenetics</topic><topic>Pharmacology. Drug treatments</topic><topic>Pharmacology/Toxicology</topic><topic>Treatment Outcome</topic><topic>Voltage-Gated Sodium Channel Blockers - administration & dosage</topic><topic>Voltage-Gated Sodium Channel Blockers - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Desaphy, Jean-François</creatorcontrib><creatorcontrib>Modoni, Anna</creatorcontrib><creatorcontrib>LoMonaco, Mauro</creatorcontrib><creatorcontrib>Camerino, Diana Conte</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Desaphy, Jean-François</au><au>Modoni, Anna</au><au>LoMonaco, Mauro</au><au>Camerino, Diana Conte</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy</atitle><jtitle>European journal of clinical pharmacology</jtitle><stitle>Eur J Clin Pharmacol</stitle><addtitle>Eur J Clin Pharmacol</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>69</volume><issue>4</issue><spage>1037</spage><epage>1039</epage><pages>1037-1039</pages><issn>0031-6970</issn><eissn>1432-1041</eissn><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>23052413</pmid><doi>10.1007/s00228-012-1414-3</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0031-6970 |
| ispartof | European journal of clinical pharmacology, 2013-04, Vol.69 (4), p.1037-1039 |
| issn | 0031-6970 1432-1041 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3621996 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Biological and medical sciences Biomedical and Life Sciences Biomedicine Diseases of striated muscles. Neuromuscular diseases Female Flecainide - administration & dosage Flecainide - therapeutic use Humans Letter to the Editors Male Medical sciences Mutation Myotonia Congenita - drug therapy Myotonia Congenita - genetics NAV1.4 Voltage-Gated Sodium Channel - genetics Neurology Nuclear Family Pharmacogenetics Pharmacology. Drug treatments Pharmacology/Toxicology Treatment Outcome Voltage-Gated Sodium Channel Blockers - administration & dosage Voltage-Gated Sodium Channel Blockers - therapeutic use |
| title | Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T15%3A11%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dramatic%20improvement%20of%20myotonia%20permanens%20with%20flecainide:%20a%20two-case%20report%20of%20a%20possible%20bench-to-bedside%20pharmacogenetics%20strategy&rft.jtitle=European%20journal%20of%20clinical%20pharmacology&rft.au=Desaphy,%20Jean-Fran%C3%A7ois&rft.date=2013-04-01&rft.volume=69&rft.issue=4&rft.spage=1037&rft.epage=1039&rft.pages=1037-1039&rft.issn=0031-6970&rft.eissn=1432-1041&rft_id=info:doi/10.1007/s00228-012-1414-3&rft_dat=%3Cproquest_pubme%3E3318056981%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1529968048&rft_id=info:pmid/23052413&rfr_iscdi=true |